Abstract
Single‐stranded phosphorothioate (PS) oligonucleotide drugs have shown potential for the treatment of several rare diseases. However, a barrier to their widespread use is that they exhibit activity in only a narrow range of tissues. One way to circumvent this constraint is to conjugate them to cationic cell‐penetrating peptides (CPPs). Although there are several examples of morpholino and peptide nucleic acids conjugated with CPPs, there are noticeably few examples of PS oligonucleotide‐CPP conjugates. This is surprising given that PS oligonucleotides presently represent the largest class of approved RNA‐based drugs, including Nusinersen, that bears the 2’‐O‐methoxyethyl (MOE)‐chemistry. In this work, we report a method for in‐solution conjugation of cationic, hydrophobic peptides or human serum albumin to a 22‐nucleotide MOE‐PS oligonucleotide. Conjugates were obtained in high yields and purities. Our findings pave the way for their large‐scale synthesis and testing in vivo.
Highlights
This page was generated automatically upon download from the ETH Zurich Research Collection
There are several examples of morpholino and peptide nucleic acids conjugated with cellpenetrating peptides (CPPs), there are noticeably few examples of PS oligonucleotideCPP conjugates
This is surprising given that PS oligonucleotides presently represent the largest class of approved RNA-based drugs, including Nusinersen, that bears the 2’-O-methoxyethyl (MOE)-chemistry
Summary
Efficient Synthesis of 2'-O-Methoxyethyl OligonucleotideCationic Peptide Conjugates Author(s): Halloy, François; Hill, Alyssa C.; Hall, Jonathan Publication Date: 2021-11-19 Permanent Link: https://doi.org/10.3929/ethz-b-000505642 Originally published in: ChemMedChem 16(22), http://doi.org/10.1002/cmdc.202100388 Rights / License: Creative Commons Attribution 4.0 International This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have